John Boozman's LLY trades

  • The latest LLY trade was a sale on Nov 21, 2025, when LLY closed at $1059.70. It closed at $1351.80 on Nov 20, 2026 (+28%).

Price changes use the closing price on each trade date, not the price actually paid, and ignore dividends. Filings report amounts only as ranges, so these figures show direction, not anyone's actual profit.

John Boozman reported 4 LLY transactions in 3 filings with the Senate eFD for 2025–2026: 2 purchases and 2 sales of Eli Lilly and Company, with trade dates from Aug 11, 2025 to Nov 21, 2025. The median gap between trade date and filing date is 27 days, and 1 trade was reported more than 45 days after it happened.

Transactions
4
Buys / sells
2 / 2
Disclosed range
$4K to $60K
Last filed
2026-08-24

LLY transactions reported by John Boozman

4 of 4 rows
TypeOwner
Eli Lilly and Company
LLY
SaleJoint$1,001 - $15,0002026-08-24
#51455bcd-4966-4e77-b481-09897ada81ae
Eli Lilly and Company
LLY
SaleJoint$1,001 - $15,0002025-12-08
#3a779539-8451-49d2-8419-d3eb72c7922a
Eli Lilly and Company
LLY
PurchaseJoint$1,001 - $15,0002025-09-12
#59bccfcc-9400-4d3d-917f-ce22a0fd2feb
Eli Lilly and Company
LLY
PurchaseJoint$1,001 - $15,0002025-09-12
#59bccfcc-9400-4d3d-917f-ce22a0fd2feb

A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.

How long disclosure took

Days from trade date to filing date for 4 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.

0–15 days
0
16–30 days
2
31–45 days
1
Over 45 days
1
Median / longest
27d / 276d

Source documents

3 Senate eFD periodic transaction reports, newest first. Each link opens the official filing.

What John Boozman's LLY filings don’t tell you

A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.

To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.

Members-only research

What members are reading this month

The thesis, the numbers behind it, and what would break it. Full access is $39 a month.

Read the full research

John Boozman and LLY: questions

Did John Boozman buy or sell LLY?

Senate eFD filings for 2025 and 2026 show 2 purchases and 2 sales of Eli Lilly and Company (LLY) reported by John Boozman, between 2025-08-11 and 2025-11-21. Reported owner: Joint.

How much LLY did John Boozman trade?

Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $4K to $60K across 4 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.

When was the last LLY filing by John Boozman?

The most recent filing that includes a LLY trade was filed on 2026-08-24. New filings appear in the Senate eFD index and are picked up when the dataset is refreshed.

Yield Theory is not affiliated with any elected official or with Eli Lilly and Company. Rows are parsed from public Senate eFD periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.

Don’t copy the filing. Read the thesis.

John Boozman LLY disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $39/month or $249/year.

$39/mo or $249/yr · cancel future renewals anytime · sources included